Weight Loss Supplement Recalled Due to Presence of Stimulant – Monthly Prescribing Reference

Hi-Tech Pharmaceuticals is recalling 1 lot of Lipodrene w/25mg Ephedra Extract Dietary Supplement due to the presence of 1,4-dimethylamylamine (DMAA).

Lipodrene w/25mg Ephedra Extract Dietary Supplement is marketed as a weight loss product. According to the Food and Drug Administration (FDA), the marketing of DMAA-containing products as dietary supplements is illegal as this amphetamine derivative is considered an unsafe food additive. Ingestion of DMAA may cause increased blood pressure or other cardiovascular issues such as shortness of breath, arrhythmias, tightening in the chest, and acute myocardial infarction

The recall involves Lot Number 001211197 (Expiration 12/25) of Lipodrene w/25mg Ephedra Extract Dietary Supplement, which was distributed in the US and Puerto Rico through online and retail sales. Individuals who have purchased the affected product should discontinue use immediately and return it to the place of purchase for a full refund.

To date, the Company has not received any reported illnesses related to this recall. Adverse reactions related to this recall should be reported to the FDAs MedWatch program.

For more information, contact Hi-Tech Pharmaceuticals at (888)-855-7919 or email recallcoordinator@hitechpharma.com.

Hi Tech Pharmaceuticals issues voluntary recall on Lipodrene w/25mg Ephedra Extract Dietary Supplement due to the presence of 1,4-dimethylamylamine (DMAA). [press release]. Silver Spring, MD: US Food and Drug Administration; May 12, 2021.

Go here to read the rest:
Weight Loss Supplement Recalled Due to Presence of Stimulant - Monthly Prescribing Reference